Abingworth as of Sept. 30, 2012
Portfolio Holdings for Abingworth
Abingworth holds 19 positions in its portfolio as reported in the September 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation (AMRN) | 41.4 | $102M | 8.1M | 12.57 | |
| Supernus Pharmaceuticals (SUPN) | 16.9 | $42M | 3.6M | 11.54 | |
| Clovis Oncology | 10.8 | $27M | 1.3M | 20.41 | |
| Alnylam Pharmaceuticals (ALNY) | 10.1 | $25M | 1.3M | 18.79 | |
| Astex Pharmaceuticals | 5.6 | $14M | 4.5M | 3.07 | |
| Incyte Corporation (INCY) | 4.3 | $11M | 581k | 18.05 | |
| OncoGenex Pharmaceuticals | 3.5 | $8.6M | 604k | 14.17 | |
| Zogenix | 2.5 | $6.2M | 2.3M | 2.64 | |
| ISIS Pharmaceuticals | 1.5 | $3.8M | 268k | 14.07 | |
| Anthera Pharmaceuticals | 1.4 | $3.5M | 3.5M | 0.99 | |
| Exelixis (EXEL) | 0.8 | $2.0M | 415k | 4.82 | |
| alexza Pharmaceuticals | 0.5 | $1.3M | 287k | 4.40 | |
| Zalicus | 0.3 | $648k | 864k | 0.75 | |
| Cornerstone Therapeutics | 0.2 | $435k | 85k | 5.13 | |
| AVANIR Pharmaceuticals | 0.1 | $360k | 113k | 3.20 | |
| Cardiome Pharma Corp | 0.1 | $159k | 481k | 0.33 | |
| EntreMed | 0.1 | $127k | 71k | 1.79 | |
| Celldex Therapeutics | 0.0 | $70k | 11k | 6.32 | |
| Poniard Pharmaceuticals (PARD) | 0.0 | $10k | 4.6k | 2.19 |
